Third IUI Failed: What Now

If you are reading this after a third negative beta (three cycles of monitoring, three triggers, three procedures, three waits, three answers that were not the one you wanted), I want to start by naming where you are. You are not the same person you were before cycle one. You know the rhythms of the clinic, you know the way the catheter feels, you know exactly how long it takes for the disappointment to register after a phone call. That is a different kind of tired than the one cycle one tired you out with.

I have sat with people in this exact moment. The framing that pulls people into the next cycle is usually "the IUIs didn't work for me." That framing is doing damage, because it puts you on trial for a tool's ceiling. The same logic applies whether 1st IUI failed, what next was the question, or whether you are now looking at three negative cycles. IUI as a tool plateaued. You did not fail at it. The decision in front of you is not "try harder," and it is not even "try again." It is whether the next cycle is the right next step at all.

This post is for that sitting-in-the-room moment, before the consult that decides what comes next. It is a returning-cycle post. You have stepped through the protocol multiple times now, and you do not need anyone to re-explain what IUI is. What you may need is a clean look at what three cycles of data are actually saying.

If you need the emotional companion first, that is a legitimate choice, not a delay. The reads I would point you at: When a Cycle Doesn't Work, and How to Survive It, Failed IUI: Next Steps, and When to Pause TTC. The math will be the same in six weeks as it is today.

What the cumulative data actually shows

The unfair thing about IUI is that the curve flattens without warning you that it has flattened. Per-cycle live-birth probability stays roughly the same in cycle one, cycle two, cycle three. It does not climb with practice. What climbs is the cumulative probability: the chance that at least one of the cycles run so far has worked.³,⁴

For unexplained infertility under thirty-five, cumulative live birth across three cycles of medicated IUI runs around twenty-five to thirty-five percent.⁴ If you are reading this, your cycles fell on the other side of that probability. Cycle four would still have similar per-cycle odds. It would not be magically better.

Where the data turns is in what cycle four buys you in time and cost relative to the alternative. Cycle four IUI is not a high-probability cycle. IVF at the same age and diagnosis is a substantially higher-probability cycle. That is the comparison three cycles of data have set up.

1st IUI failed, what next: why three cycles is the checkpoint

The major guidelines all converge here, not because three is magic, but because three is enough to know something.

• ASRM (2020) recommends reassessment after three to four cycles of medicated IUI in unexplained infertility under thirty-five, and sooner in older patients.⁷
• NICE NG156 in the UK permits up to six cycles before moving to IVF on cost-of-care grounds, but the same document recommends earlier reassessment if there is a reason to believe IUI is not the right tool.⁶
• The FORT-T trial (Reindollar 2010, Goldman 2014) randomised women aged thirty-eight to forty-two and found that skipping the clomid-IUI step and moving faster to IVF reduced time-to-pregnancy and cost per live birth.¹,² This is the trial that changed thinking for older patients. After three failed IUIs at thirty-nine, the FORT-T data is squarely on the table.
• The cumulative-curve data from observational series and Cochrane reviews of IUI shows the flattening between cycle three and cycle four.³,⁴

Three cycles is not a deadline. It is a checkpoint. The question at three is not "should I keep doing this," it is "what do three cycles together tell me, and is the next step still IUI?"

What the cycle-3 review should cover

Before any decision about cycle four or IVF, the three cycles you have already run should be looked at together. Patterns across cycles tell you more than any single cycle did.

• Was ovulation confirmed every cycle? Mid-luteal progesterone over three nanograms per millilitre on each cycle. If any cycle did not ovulate, that is a flag worth understanding.
• Endometrial thickness on the day of trigger across all three cycles. Was lining consistently at or above seven millimetres? Was there thinning on clomid that should have prompted a switch to letrozole earlier?
• Follicle count and size at trigger: was there a mature follicle every time? Single or multiple? Cancelled cycles in the mix?
• Post-wash total motile count: was it consistent across cycles, or moving around? A drop between cycle one and cycle three may indicate a partner-side change worth a urology referral.
• Trigger timing and insemination timing: was the trigger fired at the right lead follicle size? Was insemination within the standard window?
• Any cycle abnormalities: functional cysts, early LH surge, fluid in the cavity, a missed monitoring window.

If your clinic cannot put the three cycles side by side and tell you what they show, that is a useful piece of information on its own, and a reasonable trigger for a second opinion.

The diagnostic workup that may have been skipped

Many clinics start cycle one of medicated IUI before the full diagnostic workup is complete. That is reasonable practice when the prognosis is good and time matters. After three failed cycles, the unfinished workup is worth completing before any further decision.

• HSG (hysterosalpingogram) if you have not had one yet. IUI mechanically requires patent fallopian tubes. Some clinics test before cycle one, some do not.
• Saline infusion sonohysterogram (SIS) if the HSG suggested a uterine cavity abnormality, or if a polyp or fibroid is suspected.
• AMH and antral follicle count if not done recently. These do not affect IUI prognosis much, but they are central to predicting IVF success and to the IVF protocol choice.
• Repeat semen analysis if the last one is older than six months. Add sperm DNA fragmentation testing if there is recurrent loss in the picture, advanced paternal age, or a history of urology issues.
• Endometrial workup for chronic endometritis: biopsy with CD138 staining is offered in some protocols, particularly when there is unexplained implantation failure. The evidence is mixed.
• Recurrent loss panel and karyotype are usually reserved for recurrent pregnancy loss, not failed IUI. They are not standard after three negative betas without prior positive tests.

A diagnostic month is not a delay. It is information that changes what the next cycle should look like, whether that cycle is IUI #4 or IVF #1.

The IVF conversation: what changes

If the next step is IVF, what changes is not just the procedure. It is the kind of information each cycle produces.

Per-cycle live birth with IVF is a step function above IUI in most demographics. Under thirty-five, IVF per-cycle live birth typically runs forty to fifty percent; at thirty-five to thirty-seven, thirty to forty percent; at thirty-eight to forty, twenty to thirty percent.⁵ IUI in the same age bands is in the eight to fifteen percent range. The comparison is not subtle.

IVF also gives the embryologist a view of fertilisation and embryo development that IUI never provides. A failed fertilisation in IVF is itself a diagnosis: it can point to a male-factor problem the semen analysis did not catch, or to an oocyte quality issue. Three failed IUIs gave you no such diagnostic information. They gave you three negative betas.

ICSI, when added to IVF, bypasses the sperm-quality threshold that IUI requires. For couples with borderline male factor that has been the working hypothesis, ICSI is often the more honest test of whether the issue is fertilisation or implantation.

The cost arithmetic is the conversation people skip and then regret skipping. One IVF cycle typically costs four to six times one medicated IUI cycle in self-pay terms, but the per-cycle live birth is three to five times higher in the right demographics. The cost-per-baby calculation often favours IVF earlier than the cost-per-cycle calculation suggests. The detailed math lives in IUI Cost Benefit vs IVF.

Options that are not "next IUI" and not "IVF"

Two paths is not the full menu. After three cycles, there is often a third path that has not been named yet.

• A diagnostic break: one to three months for additional workup before any decision. This is not "giving up." It is buying yourself information.
• A second opinion: appropriate if monitoring was inadequate across the three cycles, if your protocol never changed cycle to cycle, or if the consult after cycle three is the same script as the consult after cycle one. A different RE may read the same data differently. They may also confirm the plan, which is also useful.
• Donor egg or donor sperm: relevant only for specific diagnoses such as diminished ovarian reserve, severe male factor, or a family history of a genetic condition you do not want to transmit. Donor pathways change the IUI math significantly; donor sperm with no female factor is one of the highest-prognosis IUI scenarios.
• Adoption, donor embryo, surrogacy: these are not consolation prizes and they are not "what's left." They are different paths to a family that some couples actively choose at this point. They are covered in Changing Direction: IVF, Donor, Adoption.
• A pause: stepping away for a defined period (three months, six months, a year) without committing to what comes after. Pausing is not failing. It is also a real option, covered in When to Pause TTC.

The reason to name all five paths is that "IUI again or IVF now" is not the whole question. Pretending it is forces a decision in two directions when the right answer for you might be in a third.

Questions to bring to the post-cycle-3 consult

The consult after cycle three is the most important one in this section of the journey. Write the questions down. The appointment is short, and you will be tired.

1. What did the three cycles together tell you about my biology? Not cycle three on its own. The pattern across all three.
2. Why do you think we haven't conceived? A good RE will have a hypothesis or a list of hypotheses. "We don't know" is sometimes the honest answer, but it should be followed by "and here is how we would investigate."
3. What is my predicted live birth with cycle four IUI versus cycle one IVF, given my age, diagnosis, and what we have learned?
4. What workup do you want to do before any decision: IUI, IVF, or pause?
5. What does my AMH and antral follicle count say about IVF prognosis? If these are not on file, why not?
6. Is there anything I should be doing in the next month, regardless of which path we pick?

If the consult does not give you a clear-eyed answer to most of those, that is the cue to seek a second opinion. Not because your team is wrong, but because the decision is large enough that it deserves a second pair of eyes. The "1st IUI failed, what next" question was always going to grow into this one; the difference now is that you have three cycles of data to answer it with.

What's next

• If you want to think about pacing, back-to-back or break: Back-to-Back IUI Cycles vs Taking a Break
• If the next step is IVF: IVF Step by Step
• For the stopping-rule pillar: How Many IUIs Should You Do Before Moving On
• If you need the emotional companion: When a Cycle Doesn't Work, and How to Survive It
• If the right answer is pause: When to Pause TTC
• If you want to prep for the consult: Questions After a Failed Cycle

Sources

1. Reindollar RH, Regan MM, Neumann PJ, et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the Fast Track and Standard Treatment (FASTT) trial. Fertility and Sterility 2010;94(3):888-899. Link
2. Goldman MB, Thornton KL, Ryley D, et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertility and Sterility 2014;101(6):1574-1581.e2. Link
3. Diamond MP, Legro RS, Coutifaris C, et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility (AMIGOS/FAST-T). New England Journal of Medicine 2015;373(13):1230-1240. Link
4. Cohlen B, Bijkerk A, Van der Poel S, Ombelet W. IUI: review and systematic assessment of the evidence that supports global recommendations. Human Reproduction Update 2018;24(3):300-319. Link
5. Bahadur G, Homburg R, Bosmans JE, et al. Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles. BMJ Open 2020;10(3):e034566. Link
6. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE guideline NG156. 2013, updated 2017. Link
7. Practice Committee of the American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertility and Sterility 2020;113(2):305-322. Link